Seltorexant

Generic Name: Seltorexant

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₂FN_₇O

CAS Number: 1452539-75-1

Unique Ingredient Identifier: AIS8N3O50B

Background: Seltorexant is under investigation in clinical trial NCT03494907 (A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

Phase 2

Completed

Conditions: Insomnia

Interventions: Drug: JNJ-42847922
Drug: Placebo

First Posted Date: 2015-06-08

Last Posted Date: 2024-12-09

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 28

Registration Number: NCT02464046

Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: JNJ-42847922
Drug: Itraconazole

First Posted Date: 2015-05-28

Last Posted Date: 2017-07-11

Lead Sponsor: Janssen Cilag N.V./S.A.

Target Recruit Count: 16

Registration Number: NCT02455856

A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants

Phase 1

Completed

Conditions: Depressive Disorder, Major

Interventions: Drug: JNJ-42847922
Other: Placebo

First Posted Date: 2014-02-20

Last Posted Date: 2016-02-04

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 20

Registration Number: NCT02067299

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy